Cristina Mir

Barcelona, CT 08035, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma.

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma.

Journal: Cancers

Published: October 21, 2022

Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy.

Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy.

Journal: Seminars in cancer biology

Published: November 30, 2021

RNA-binding proteins: Underestimated contributors in tumorigenesis.

RNA-binding proteins: Underestimated contributors in tumorigenesis.

Journal: Seminars in cancer biology

Published: November 23, 2021

TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: November 08, 2021

The Role of Sphingolipids Metabolism in Cancer Drug Resistance.

The Role of Sphingolipids Metabolism in Cancer Drug Resistance.

Journal: Frontiers in oncology

Published: November 02, 2021

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.

Journal: Cancers

Published: September 07, 2021

Targeting Sphingolipids for Cancer Therapy.

Targeting Sphingolipids for Cancer Therapy.

Journal: Frontiers in oncology

Published: July 21, 2021

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance.

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance.

Journal: Cancers

Published: September 08, 2020

Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals.

Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals.

Journal: Frontiers in oncology

Published: July 22, 2020

Autophagy Takes Center Stage as a Possible Cancer Hallmark.

Autophagy Takes Center Stage as a Possible Cancer Hallmark.

Journal: Frontiers in oncology

Published: July 22, 2020

Insights into new mechanisms and models of cancer stem cell multidrug resistance.

Insights into new mechanisms and models of cancer stem cell multidrug resistance.

Journal: Seminars in cancer biology

Published: May 28, 2019

Autophagy inhibition as a promising therapeutic target for laryngeal cancer.

Autophagy inhibition as a promising therapeutic target for laryngeal cancer.

Journal: Carcinogenesis

Published: April 11, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026